Indication

Idiopathic Infantile Hypercalcaemia

1 clinical trial

1 product

Clinical trial

Rifampin to Reduce Elevated Levels of Blood and Urine Calcium in Patients With Inactivating Mutations in the CYP24A1 Gene

Status: Recruiting, Estimated PCD: 2026-12-01

Product